《亞洲股市》越南及臺股續升0.7%跑贏 港股反覆倒跌
美股期貨全面回吐近0.3%。日股今天假期休市。亞太區股市個別發展,但升跌均少於1%。越南(VNI)及臺灣加權指數分別五連升及四連升兼跑贏,報1,479及17,582,均升0.7%。深成續升0.4%半日收12,381。
然而,港股、新西蘭、馬來西亞及南韓股市反覆逆軟,南韓(KOSPI)扭三連升,報2,695,回吐0.4%。恆指在騰訊(00700.HK)、京東(09618.HK)和美團(03690.HK)倒跌1%-4%,以及地產分類指數回吐1.3%,金融分類指數也反覆偏軟拖累,蒸發今早高開410點或1.9%至21,823所有升幅倒跌,最低見21,333,半日收21,394,倒跌18點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.